Intestinal endocrine progenitor cells from mice have the potential to be converted into insulin-secreting cells by inhibiting Foxo one or stimulating the expression of Pdx1, MafA, and Ngn3, and can be used as a complementary source in diabetes transplantation therapy (Bouchi et al., 2014; Chen et al., 2014). This evidence concerns the gene INS and diabetes mellitus.